Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
±Û¸®º¤Ä°¼¿100mg - »õâ
|
Novartis |
E01630891 | Imatinib mesylate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
±Û¸®º¤Çʸ§ÄÚÆÃÁ¤100mg - »õâ
|
Novartis |
E01631151 | Imatinib mesylate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
±Û¸®º¤Çʸ§ÄÚÆÃÁ¤100mg - »õâ
|
Çѱ¹³ë¹ÙƼ½º |
E01631441 | Imatinib mesylate | Àü¹®ÀǾàǰ | ±Þ¿© |
| imatinib mesylate |
A drug that is being studied for its ability to inhibit the growth of certain cancers. It interferes with a portion of the protein produced by the bcr/abl oncogene. Also called Gleevec and STI571.
Ãâó: www.stjude.org/glossary
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|